Brief: Leap Therapeutics Acquires Flame Biosciences

Cypherpunk Technologies

17/01/2023 13:50

Jan 17 (Reuters) - Leap Therapeutics Inc  LPTX.O :
    * LEAP THERAPEUTICS ACQUIRES FLAME BIOSCIENCES
    * LEAP THERAPEUTICS INC: PROPOSED DEAL ADDS FL-301, CLINICAL
STAGE
ANTI-CLAUDIN18.2 ANTIBODY, AND TWO PRECLINICAL ANTIBODY PROGRAMS
TO LEAP'S PIPELINE
    * LEAP THERAPEUTICS INC - TOTAL CASH BALANCE OF COMBINED
COMPANY
AS OF DECEMBER 31, 2022 WAS APPROXIMATELY $115 MILLION
    * LEAP THERAPEUTICS: TO ISSUE ABOUT 19.8 MILLION SHARES,
136,833
NEWLY DESIGNATED SERIES X NON-VOTING CONVERTIBLE PREFERRED
SHARES TO FLAME STOCKHOLDERS

Source text for Eikon:  ID:nPn29GbRa 
Further company coverage:  LPTX.O